A Study to Evaluate the Effect of Saroglitazar Magnesium on the QTc Interval in Healthy Volunteers

NCT04045769 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

52

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Saroglitazar magnesium 4mg
DRUG: Placebos
DRUG: Moxifloxacin 400mg
DRUG: Saroglitazar magnesium 20 mg

Sponsor

Zydus Therapeutics Inc.